ClinicalTrialsFinder

Cardiovascular Disease and Lipoprotein(a) Clinical Trials in Aarhus N

1 recruitingAarhus N, Denmark

Showing 1–1 of 1 trials

Recruiting
Phase 3

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals5,700 enrolled618 locationsNCT07517263